GenVec was a clinical-stage biopharmaceutical company founded in 1992 and headquartered in Gaithersburg, Maryland, that pioneered adenovector (AdenoVerse) gene-delivery technology to develop gene-based therapeutics and vaccines, including programs for hearing loss and balance disorders. - View it on GitHub